ArticleWorld journal of hepatology2022

Cystic fibrosis patients on cystic fibrosis transmembrane conductance regulator modulators have a reduced incidence of cirrhosis.

Mitchell L Ramsey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.